Uremic pruritus is associated with higher Kt/V and serum calcium concentration

Clinical Nephrology

Volumn 66, Issue 3, 2006, Pages 184-191

  Duque, M I ^a   Thevarajah, S ^a   Chan, Y H ^b   Tuttle, A B ^a   Freedman, B I ^a   Yosipovitch, G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Dermatology; End stage; Hemodialysis; Pruritus; Quality of life; Renal disease

Indexed keywords

ANTIHISTAMINIC AGENT; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXERCALCIFEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER; VITAMIN D DERIVATIVE;

ADULT; AFRICAN AMERICAN; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; DRY SKIN; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; PATIENT SELECTION; PHOSPHATE BLOOD LEVEL; PREVALENCE; QUALITY OF LIFE; RISK FACTOR; SKIN PRURITUS; TREATMENT DURATION; UNITED STATES; UREMIA; VISUAL ANALOG SCALE;

EID: 33748641733     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp66184     Document Type: Article

References (42)

1. Altmeyer P, Kachel HG, Junger M, Koch KM, Holzmann H. Skin changes in long-term dialysis patients. Hautarzt. 1982; 33: 303-309.
2. Ascer E, Bertolami MC, Venturinelli ML, Buccheri V, Souza J, Nicholau JC, Ramires JA, Serrano CV. Atorvastatin reduces proinflammatory markers in hypercholeserolemic patients. Atherosclerosis. 2004; 177: 161-166.
3. Centers for Disease Control and Prevention (CDC). State-specific trends in chronic kidney failure-United States, 1990-2001. MMWR Morb Mortal Wkly Rep. 2004; 53: 918-920.
4. Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001; 5: 105-110.
5. Coresh J, Astor BC, Greene T, Ecknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003; 41: 1-12.
6. Feingold KR, Man MQ, Menon GK, Cho SS, Brown BE, Elias PM. Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest. 1990; 86: 1738-1745.
7. Feldman H, Klag MJ, Chiapella AP, Whelton PK. End-stage renal disease in U.S. minority groups. Am J Kidney Dis. 1992; 19: 397-410.
8. Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, Main CJ, Griffiths CE. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol. 2003; 139: 752-756.
9. Griffiths CE, Richards HL. Psychological influences in psoriasis. Clin Exp Dermatol. 2001; 26: 338-342.
10. Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol. 2000; 11: 330-334.
11. Gupta A, Gupta AK. Psychiatric and psychological comorbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003; 4: 833-842.
12. Hampers CL, Katz AI, Wilson RE, Merrill JP. Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med. 1968; 279: 695-697.
13. Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis. 1995; 25: 413-419.
14. Ikoma A, Rukwied R, Stander S, Steinhoff M, Miyachi Y, Schmelz M. Neurophysiology of pruritus: interaction of itch and pain. Arch Dermatol. 2003; 139: 1475-1478.
15. Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, Stulten C, van der Kuip H, Pauli-Magnus C, Raub U, Kuhlmann U, Mettang T. The role of microinflammation in the pathogenesis of uraemic pruritis in haemodialysis patients. Nephrol Dial Transplat. 2006; 21: 749-755
16. Kleeman CR, Massry SG, Popovtzer MM, Makoff DL, Maxwell MH, Coburn JW. The disappearance of intractable pruritus after parathyroidectomy in uremic patients with secondary hyperparathyroidism. Trans Assoc Am Physicians. 1968; 81: 203-212.
17. Lee SH, Elias PM, Proksch E, Menon GK, Mao-Quiang M, Feingold KR. Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest. 1992; 89: 530-538.
18. Li S, McAlpine D, Liu J, Collins AJ. Differences between black and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther. 2004; 11: 5-13.
19. Liao JK, Laufs U. Pleiotropic effects of statins. Ann Rev Pharmacol Toxicol. 2005; 45: 89-118.
20. Massry SG, Popovtzer MM, Coburn JW, Makoff DL, Maxwell MR, Kleeman CR. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med. 1968; 279: 697-700.
21. Mettang T, Fritz P, Weber J, Machleidt C, Hubel E, Kuhlmann U. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol. 1990; 34: 136-141.
22. Mettang T, Pauli-Magnus C, Mark D. Uremic pruritus - new perspectives and insights from recent trials. Nephrol Dial Transplant. 2002; 17: 1558-1563.
23. Mettang T, Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, Stulten C, Kuip H, Pauli-Magnus C, Kuhlmann U. 2nd International Workshop for the Study of Itch. Toyama, Japan: 2003.
24. Momose A, Kudo S, Satko M, Saito H, Nagai K, Katabira Y, Funya T. Calcium ions are abnormally distributed in the skin of haemodialysis patients with uraemic pruritus. Nephrol Dial Transplant. 2004; 19: 2061-2066.
25. Ostlere LS, Taylor BC, Baillod R, Wright R. Relationship between pruritus, transepidermal water loss, and biochemical markers of renal itch in haemodialysis patients. Nephrol Dial Transplant. 1994; 9: 1302-1304.
26. Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, Risler T, Berger ED, Kuhlmann U, Mettang T. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol. 2000; 11: 514-519.
27. Proksch E. Antilipemic drug-induced skin manifestations. Hautarzt. 1995; 46: 76-80.
28. Raap U, Werfel T, Jaeger B, Schmid-Ott G. Atopic dermatitis and psychological stress. Hautarzt. 2003; 54: 925-929.
29. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E, PROVE IT-TIMI 22 Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005; 352: 20-28.
30. Robinson-Bostoin L, DiGiovanna JJ. Cutaneous manifestations of end-stage renal disease. Am Acad Dermatol. 2000; 43: 975-986.
31. Sawaya BP, Butros R, Naqvi S, Geng Z, Mawad H, Friedler R, Fanti P, Monier-Faugere MC. Differences in bone turnover and intact PTH levels between African-American and Caucasian patients with end-stage renal disease. Kidney Int. 2003; 64: 737-742.
32. Schwartz IF, Iania A. Uremic pruritus. Nephrol Dial Transplant. 1999; 14: 834-839.
33. Szepietowski JC. Selected elements of the pathogenesis of pruritus in haemodialysis patients. Med Sci Monit. 1996; 2: 343-347.
34. Szepietowski JC, Schwartz RA. Uremic pruritus. Int J Dermatol. 1998; 37: 247-253.
35. Szepietowski JC, Sikora M, Kusztal M, et al. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J Dermatol. 2002; 29: 621-627.
36. Szepietowski JC, Reich A, Schwartz RA. Uremic xerosis. Neph Dial Transplant. 2004; 19: 2709-2712.
37. Szepietowski JC, Salomon J. Uremic pruritus: Still an important clinical problem. J Am Acad Dermatol. 2004; 51: 842-843.
38. Urbonas A, Schwartz RA, Szepietowski JC. Uremic pruritus - an update. Am J Nephrol. 2001; 21: 343-350.
39. Yosipovitch G, Zucker I, Boner G, Gafter U, Shapira Y, David M. A questionnaire for the assessment of pruritus: Validation in uremic patients. Acta Derm Venereol. 2001; 81: 108-111.
40. Yosipovitch G, Fast K, Bernhard JD. Noxious heat and scratching decrease histamine-induced itch and skin blood flow. J Invest Dermatol. 2005; 125: 1268-1272.
41. Zili J, Achour A, Mhallas S, Frih A, Dian N, El May M. Les manifestations dermatologiques chez les hemodialyses chroniques. Nouv Dermatol. 1994; 13: 567.
42. Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol. 2003; 49: 842-846.